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Abstract  
BACKGROUND: Diabetes mellitus (DM) is one of the most prevalent diseases all over the world. Prevalence of 
DM in Turkey is 13.7%. Depression is another condition which has a high prevalence. All over the world, an 
estimated 300 million people of all ages suffer from depression. The relevance between depression and DM is a 
well - known condition. 
AIM: We aimed in this study to find out the prevalence of depression symptoms for DM in an attempt to better 
manage the disease. 
METHODS: We preferred the Beck Depression Index (BDI) to evaluate the depression symptoms. 
RESULTS: The number of patients introduced the study were 171 (101 (59.1%) female). As a results of BDI 67 
(39.2%) patients evaluated as normal [29 (28.7%) female], 54 (31.6%) had poor symptoms [35 (34.7%) female], 
46 (26.9%) had moderate symptoms [34 (33.7%) female] and lastly only 4(2.3%) had strong symptoms 3 (3.0%) 
female]. So 50 (29.2%) of patients had median plus strong symptoms. There were statistically significant 
association between HbA1c stages and depression (P = 0.018). 
CONCLUSION: Being a patient with DM is a strong indicator that the patient may have a depressive disorder. So 
the physician who takes care patients with DM should be alert about depression, and the simplest way to 
accomplish is BDI. 
 
 
 
 
 
 
 
Introduction 
 
Diabetes mellitus (DM) is one of the most 
prevalent diseases all over the world and has 
devastating complications for patients and economic 
burden for nations [1]. Prevalence of DM in Turkey 
has increased from 7.2% [2] to 13.7% [3] in 8 years. 
Depression is also a condition with high 
prevalence. All over the world, an estimated 300 
million people of all ages suffer from depression [4]. 
Also, the World Health Organization (WHO; 2010) 
declared that major depression carries the heaviest 
burden of disability among mental and behavioural 
disorders (3.7 % of all U.S. disability-adjusted life 
years; and 8.3% of all U.S. years lived with disability) 
[5].  
A study conducted in Istanbul determined that 
40.1% of all participants have moderate to severe 
depressive symptoms [6]. Furthermore, it is observed 
to be prevalent in the city that the study is conducted. 
The correlation between depression and DM 
is a well - known condition which is investigated by 
many researchers [7]. Prevalence of depression in 
patients with DM may vary according to the type of 
DM, gender and conditions they live in. While the DM 
is a serious and important condition, depression must 
be recognised to manage better and improve the 
condition to prevent devastating outcomes well known 
for DM. 
This study aims to reveal the prevalence of 
depressive symptoms among patients with diabetes in 
our region. This way, we can rightly presume and 
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diagnose depression in patients with DM and manage 
it more precisely to improve outcome. 
 
 
Methods 
 
We selected patients randomly who came for 
their routine Diabetes control as outpatients. After 
evaluation of biochemical parameters along with 
patient’s condition and informing the patient about the 
test, the Beck Depression Index form was given to the 
patient to fill out either at the clinic or to take home. 
Data of 171 diabetic patients were collected, 
recorded and evaluated on SPSS 20 statistical 
program. 
The study was conducted in a cross-sectional 
manner to find out if a correlation exists between 
depression symptoms and DM. Parameters used were 
HbA1c values along with independent parameters like 
age, gender and educational background. The study 
was carried out in Sakarya Research and Training 
Hospital in Turkey from December 2016 to January 
2017. All the patients had diabetes. The exclusion 
criteria for patients were a diagnosis of depression 
and using any antidepressant drug. 
The sample population consisted of 171 
patients with diabetes. Within this population, 96 typed 
2 using the oral antidiabetic drug (OAD), 61 were 
using OAD plus insulin, 5 patients were using insulin 
only, 2 were prediabetic, and 7 were type 1. We used 
the Beck Depression Index (BDI) to evaluate 
depression symptoms. 
BDI was developed by Aron T. Beck. In BDI 
there are 21 questions and 4 answers to choose, and 
each question is graded from 0 - 3. The total points 
are calculated and assigned ranging 0-9 is normal, 10 
- 16 poor, 16 - 30 modest and over 30 is strong 
[14][15]. 
Before using the BDI, the conducting 
physician has been trained by psychologists. The BDI 
questionnaire forms were given to patients at the time 
of regular visit and had been collected for review. All 
the forms were recorded together with other 
parameters on SPSS 20 statistical program and then 
evaluated. A p-value ≤ 0.05 was accepted as 
statistically significant. Parameters such as gender, 
age, marital status, and educational background, the 
age of patient’s diabetes, diabetes therapy, HbA1c 
and other biochemical parameters that were collected 
in 3-month intervals were recorded. These were then 
reviewed to determine the relationship between these 
parameters and depression symptoms. 
HbA1c is the strongest indicator for DM status 
and is used to find out the control level of the disease 
and to direct therapy [13]. HbA1c is analysed with the 
PremierHb9210
TM 
HbA1c analyser. We stratified 
HbA1c in five stages as 5.0 - 6.5, 6.5 - 7.0, 7.0 - 8.0, 
8.0 - 9.5 and over 9.5 [12] and we calculate a mean 
value of A1c for each patient collected in years to 
determine the relevant stage of A1c. 
The study protocol was approved by ethics 
committee of Sakarya University. Approval was 
obtained on July 31 of 2016 with the number of 
71522473/050.01.04/18. Before giving the 
questionnaire forms, all patients were informed about 
the test, and their approvals were taken. 
 
 
Results 
 
There were 171 patients. The majority of 
patients were female (n = 101; 59.1%).The mean age 
was 59.11yrs with a min 30yrs, and a max 79yrs and 
the majority of patients were under 65 years old 
(77.2%). fifteen (8.8%) patients were illiterate, 100 
(58.5%) elementary school, 18 (10.5%) middle school, 
28 (17.0%) high school and 9 (5.3%) had college 
degrees. The marital status of patients were 2 (1.2%) 
single, 157 (91.8%) married, 2 (1.2%) divorced and 10 
(5.8%) widowed. Most of the patients were 
housewives (94; 55%), and the rest were retired 
(26.9%), and 28 patients had other jobs, and only 3 
were jobless. Smoking status of patients was 96 
(56.1%) never smoked, 34 (19.9%) currently smoking 
and 41 (24%) had smoked before. Alcohol status of 
the patients was; 160 (93.6%) were alcohol naïve, 8 
(4.7%) had rarely used, and 3 (1.8%) had previously 
used. Mean duration of diabetes was 13.47 years 
(ranging from newly diagnosed to 36 years). Data 
were collected over a mean period of 7. 68 years. 
DM treatment profile of patients were Oral 
Antidiabetic Drug (OAD) 97 (56.7%), insulin 12 (7%) 
and OAD + insulin 62 (36.3%). Most of the patients 
had concurrent diseases especially hypertension [118 
(69%)] and dyslipidemia [141 (82.5 %)]. Further 16 
(9.4%) patients had ischemic heart disease (IHD), and 
16 (9.4%) hypothyroid, and also 1 had allergic 
asthma, 1 colitis, 1 hepatitis carrier, 1 chronic 
obstructive pulmonary disease, 1 ischemic heart 
disease + asthma bronchial, 1 larynx carcinoma (CA), 
1 has had tuberculosis, 1 premature menopause, 1 
prostate CA, 2 rheumatoid arthritis and 1 ulcerative 
colitis. 
As mentioned before we tried a new method 
of staging HbA1c (We stratified HbA1c in five stages 
as 5.0 - 6.5, 6.5 - 7.0, 7.0 - 8.0, 8.0 - 9.5 and over 9.5) 
to reveal the association between HbA1c and 
depression. The relevance is depicted in the table. 
Also as shown in Figure 1, there was a statistically 
significant association between HbA1c stages and 
depression p = 0.018. 
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Figure 1: Relation between depression and mean A1c stage 
 
As a results of Beck Depression Index 67 
(39.2%) patients appreciated as normal [29 (28.7%) 
female and 38 (54.3%) male], 54 (31.6%) had poor 
symptoms [35 (34.7%) female and 19 (27.1%) male], 
46 (26.9%) had moderate symptoms [34 (33.7%) 
female and 12%) male] and lastly only 4 (2.3%) had 
strong symptoms [3 (3.0%) female and 1 (1.4%) 
male]. Therefore, 50 (29.2%) of patients had shown 
median plus strong symptom (Table 1). 
Table 1: Correlation between depression symptoms and 
gender, education, DM age and HbA1c levels 
  Normal 
Poor 
Symptoms 
Med 
Symptoms 
Strong 
Symptoms 
P 
Subjects Total N=171 67(39.18%) 54(31.57%) 46(26.90%) 4(2.33%)  
Gender 
Female n=101 
(59.06%) 
29(28.7%) 35(34.7%) 34(33.66%) 3(2.97%) 
0.007 
Male n=70 
(40.93%) 
38(54.3%) 19(27.1%) 12(17.1%) 1(1.4%) 
Education 
No Education 
n=15  (8.77%) 
4(26.7%) 6(40.0%) 4(26.7%) 1(6.7%) 
0.459 
Pre n=100 
(58.47%) 
40(40%) 25(25%) 32(32%) 3(3.0%) 
Med n=18 
(10.52%) 
6(33.3%) 7(38.9%) 5(27.8%) 0(0.0%) 
High n=29 
(16.95%) 
14(48.3%) 11(37.9%) 4(13.8%) 0(0.0%) 
University n=9 
(5.26%) 
3(33.3%) 5(55.6%) 1(11.1%) 0(0.0%) 
DM Age 
0-5 Years n=16 
(9.4%) 
7(43.75%) 6(37.5%) 3(18.75%) 0(0%) 
0.863 
6-10 Years n=47 
(27,4%) 
21(44.68%) 14(29.78%) 11(23.40%) 1(2.12%) 
11 Years And 
Over  n=108 
(63.2%) 
39(33.33%) 40(34.18%) 35(29.91%) 3(2.56%) 
HbA1c 
Levels 
%5,0-6,5 n=36 
(21.05%) 
16(44.4%) 11(30.6%) 9(25.0%) 0(0.0%) 
0.018 
%6.5-7.0 n=39 
(22.80%) 
15(38.5%) 14(35.9%) 8(20.5%) 2(5.1%) 
%7.0-8.0 n=40 
(23.39%) 
21(52.5%) 13(32.5%) 6(15.0%) 0(0.0%) 
%8,0-9.5 n=34 
(19.88%) 
12(35.3%) 8(23.5%) 13(38.2%) 1(2.9%) 
%9,5> n=22 
(12.86%) 
3(13.6%) 8(36.4%) 10(45.5%) 1(4.5%) 
 
While the relationship between DM type and 
depression symptoms was not statistically significant 
in a general mean (P = 0.892) statistically significant 
differences between patients with type 2 OAD (25% 
moderate plus strong symptoms) and patients with 
type 2 OAD plus Insulin (32.8 % moderate plus strong 
symptoms) was noted (Table 2). 
Table 2: Correlation between depression symptoms and DM 
type, HT and dyslipidemia 
  Normal 
Poor 
Symptoms 
Med 
Symptoms 
Strong 
Symptoms 
P 
Prediabetes n=2 (1.16%) 
1(1.5%)C↓ 0(0.0%) 1(2.2%) 2(1.2%) 
0.879 
(50%)R→ (0.00%) (50%) (0.00%) 
Type 1 Diabetes n=7  (4.09%) 
1(1.5%) 2(3.7%) 4(8.7%) 0(0.0%) 
(14.2%) (28.57%) (57.1%) (0.00%) 
Type 2 DM 
(OAD) 
n=96  
(56.14%) 
39(58.2%) 
(40.62%) 
33(61.1%) 
(34.37%) 
22(47.8%) 
(22.91%) 
2(50.0%) 
(2.08%) 
Type 2 DM 
(Insulin) 
n=5  (2.92%) 
2(3.0%) 2(3.7%) 1(2.2%) 0(0.00%) 
(40.00%) (40%) (20%) (0.00%) 
Tip 2 DM 
OAD&Insulin 
n=61 
(35.67%) 
24(35.8%) 17(31.5%) 18(39.1%) 2(50.0%) 
(39.34%) (27.86%) (29.50%) (3.27%) 
Hypertension 
Yes n=118 
(69.00%) 
49 
(41.5%) 
34 (28.8%) 32 (27.1%) 3 (2.5%) 
0.675 
No n=53 
(30.99%) 
18 (34%) 20 (37.7%) 14 (26.4%) 1 (1.9%) 
Dyslipidemia 
Yes n=141 
(82.45%) 
54 
(38.3%) 
45 (31.9%) 39 (27.7%) 3 (2.1%) 
0.916 
No n=30 
(17.54%) 
13 
(43.3%) 
9 (30%) 7 (23.3%) 1 (3.3%) 
 
Although high school (13.8%) and college 
(11.1%) degree patients had less moderate 
depression symptoms, it should be kept in mind that 
most of the patients (n = 100) had elementary school 
degree. P = 0.59 (Table 1). 
The association between dyslipidemia and 
hypertension is detailed in Table 2 respectively. 
 
 
Discussion 
 
This study investigated depression symptoms 
and its association with some parameters in patients 
with DM. This study revealed that 29.2 % of patients 
with DM have depression symptoms. It should be kept 
in mind that BDI results given here are not diagnostic 
but rather to give direction for further referral to a 
specialist. Most of the patients who have depression 
symptoms were female. Some studies found a high 
prevalence between depression and DM [8] and the 
results of our study complied with these results. 
DM patients with depression are more prone 
to poor glycemic control in general. This vulnerability 
is yet to be explicitly understood. It is thought that 
depression is caused by changes of the 
neurotransmitters in the brain. These are dopamine, 
serotonin and norepinephrine. These affect mood and 
behaviour. Counterregulatory hormones such as 
catecholamines, glucocorticoids, glucagon and growth 
hormones are secreted during psychological stress 
[9]. Activation of counter-regulatory hormones 
counteract the insulin action and can worsen glucose 
excursion. Increasing glucose levels may complicate 
the control of diabetes. And poor glycemic control 
especially in DM with complications could worsen 
depression symptoms and could lessen the response 
to antidepressant therapy [10]. While the relationship 
between depression and DM is well known, only 31% 
of patients with DM and depression use 
antidepressant therapy [11]. 
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In our study based on BDI, we found that 
29.2% of patients with DM had depression symptoms 
with prevalence higher in females (36.7% moderate 
plus strong symptoms) when compared to males 
(18.5% moderate plus strong symptoms), p = 0.001. 
In conclusion, the prevalence of depression 
symptoms in patients with diabetes in a region where 
Turkish people live was somewhat higher than 
reported for other countries. Being a diabetic 
especially a female and having a poor managed DM 
were strong indicators that the patient may have 
depressive disorder. Hence the physician who takes 
care of patients with DM should be alert to the 
possibility of depression and the simplest way to 
accomplish this is the Beck Depression Index. 
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